Efficacy and safety of refined balloon pulmonary angioplasty combined with riociguat in the treatment of inoperable chronic thromboembolic pulmonary hypertension: a single center, open label, prospective, optimal, randomized, parallel controlled clinical study (PRACTICE study)
Latest Information Update: 11 Jan 2022
At a glance
- Drugs Riociguat (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- Acronyms PRACTICE
- 27 Dec 2021 Study design has been released in the Trials
- 04 Aug 2020 New trial record